How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | RMDRESMED INC | SYKSTRYKER CORP | BSXBOSTON SCIENTIFIC CORP | BDXBECTON DICKINSON & CO | Median of the restexcluding RMD |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $253.06▲ 6.86 (2.79%) | $307.08▲ 9.48 (3.19%) | $46.01▲ 1.50 (3.37%) | $200.42▲ 6.08 (3.13%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 9.0/10 | 9.0/10 | 10.0/10 | 7.0/10 | 9.0/10 |
| Market value | $36.50B | $117.18B | $67.90B | $57.20B | |
| Revenue | $5.65B | $25.12B | $20.07B | $21.84B | |
| Profit | $1.52B | $3.25B | $2.89B | $1.68B | |
| Revenue growthChange in sales versus the prior year. | 9.9% | 11.2% | 19.9% | 8.2% | 11.2% |
| Gross marginShare of sales left after the direct cost of producing them. | 61.1% | 64.0% | 69.0% | 45.4% | 64.0% |
| Operating marginShare of sales left after running the business, before interest and tax. | 33.4% | 19.5% | 18.0% | 11.8% | 18.0% |
| Profit marginProfit kept from each dollar of sales. | 26.9% | 12.9% | 14.4% | 7.7% | 12.9% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 29.2% | 17.1% | 18.2% | 12.2% | 17.1% |
| Return on equityProfit against the owners' stake in the company. | 23.1% | 14.5% | 11.9% | 6.6% | 11.9% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | 25.9% | 10.3% | 9.2% | 5.2% | 9.2% |
| P/E ratioPrice paid per dollar of annual profit. | 23.96x | 36.10x | 23.48x | 34.09x | 34.09x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | 17.09x | 19.98x | 15.53x | 15.03x | 15.53x |
| Price to book | 5.54x | 5.23x | 2.80x | 2.25x | 2.80x |
| Debt to equityTotal liabilities compared with owners' stake. | 0.36x | 1.13x | 0.80x | 1.18x | 1.13x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 8/9 | 6/9 | 8/9 | 6/9 | 6.0 |
| Bankruptcy riskAltman Z-Score zone. | safe | safe | safe | grey |
How RMD compares with the others
- RMD's operating margin of 33.4% is higher than the median of the other companies selected (18.0%).
- Its revenue growth of 9.9% is in line with the median of the other companies selected (11.2%).
- It trades at a lower P/E than the median of the other companies selected: 24.0x against 34.1x.
- Its liabilities are lower relative to equity than the median of the other companies selected: 0.4x against 1.1x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.